Close Menu

NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its first quarter revenues increased 17 percent year over year, exceeding Wall Street expectations on the top and bottom lines.

The company's total revenue for the three months ended March 31 was $108.8 million compared to $92.6 million in the first quarter of 2018. Analysts had predicted revenues of $106.7 million on average.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.